文献速递胸部肿瘤放疗放疗物理与技术

实时自适应4D优化粒子放疗治疗不规则运动肿瘤的实验验证

Experimental Validation of a Real-Time Adaptive 4D-Optimized Particle Radiotherapy Approach to Treat Irregularly Moving Tumors.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-12-01

本研究在临床碳离子设备上实验验证了一种新策略——4D优化与实时自适应束流追踪协同的MP4DRT,用于治疗不规则运动肿瘤。在计划运动幅度20 mm的肺癌计划中,MP4DRT在所有测试的运动场景和指标下均产生最优指标,达到与静态治疗相似的适形性;D95>95%所需的运动监测精度为1.9 mm。

要点

  • MP4DRT将4D优化与实时自适应束流追踪协同,在临床碳离子设备上完成实验验证。
  • 在计划运动幅度20 mm的肺癌计划中,MP4DRT在所有测试场景和指标下均产生最优指标。
  • D95>95%所需的运动监测精度为1.9 mm。

核心结论

  • 借助临床可行的运动监测,MP4DRT可向不规则运动靶区递送高度适形的剂量分布。

研究设计与样本

  • 在临床碳离子设备的剂量递送系统中实现MP4DRT,并在类质量保证设置下对运动电离室阵列进行实验测试。
  • 测试基于虚拟肺部4DCT的周期性子集制定的肺癌计划,计划运动幅度为20 mm,并考虑变化的运动幅度和基线漂移。
  • 通过向运动信号添加噪声评估所需运动监测精度,并在可模拟非周期性运动的整个4DCT体模数据集上进行基于日志文件的剂量重建。

主要发现

  • 在所有考虑的运动场景和指标下,MP4DRT在测试的运动缓解策略中产生最优指标并递送高质量治疗。
  • MP4DRT的适形性与静态治疗相似。
  • D95>95%所需的运动监测精度为1.9 mm。

关键数值与推荐

  • 治疗质量以靶区覆盖(D95)、剂量均匀性(D5-D95)、适形数和心脏与肺剂量评估。
  • MP4DRT与MP4D、重扫描束流追踪和内靶区计划进行比较。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Treatment of locally advanced lung cancer is limited by toxicity and insufficient local control. Particle therapy could enable more conformal treatment than intensity modulated photon therapy but is challenged by irregular tumor motion, associated range changes, and tumor deformations. We propose a new strategy for robust, online adaptive particle therapy, synergizing 4-dimensional optimization with real-time adaptive beam tracking. The strategy was tested and the required motion monitoring precision was determined. METHODS AND MATERIALS: In multiphase 4-dimensional dose delivery (MP4D), a dedicated quasistatic treatment plan is delivered to each motion phase of periodic 4-dimensional computed tomography (4DCT). In the new extension, "MP4D with residual tracking" (MP4DRT), lateral beam tracking compensates for the displacement of the tumor center-of-mass relative to the current phase in the planning 4DCT. We implemented this method in the dose delivery system of a clinical carbon facility and tested it experimentally for a lung cancer plan based on a periodic subset of a virtual lung 4DCT (planned motion amplitude 20 mm). Treatments were delivered in a quality assurance-like setting to a moving ionization chamber array. We considered variable motion amplitudes and baseline drifts. The required motion monitoring precision was evaluated by adding noise to the motion signal. Log-file-based dose reconstructions were performed in silico on the entire 4DCT phantom data set capable of simulating nonperiodic motion. MP4DRT was compared with MP4D, rescanned beam tracking, and internal target volume plans. Treatment quality was assessed in terms of target coverage (D95), dose homogeneity (D5-D95), conformity number, and dose to heart and lung. RESULTS: For all considered motion scenarios and metrics, MP4DRT produced the most favorable metrics among the tested motion mitigation strategies and delivered high-quality treatments. The conformity was similar to static treatments. The motion monitoring precision required for D95 >95% was 1.9 mm. CONCLUSIONS: With clinically feasible motion monitoring, MP4DRT can deliver highly conformal dose distributions to irregularly moving targets.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Steinsberger T, Donetti M, Lis M, et al. Experimental Validation of a Real-Time Adaptive 4D-Optimized Particle Radiotherapy Approach to Treat Irregularly Moving Tumors. Int J Radiat Oncol Biol Phys. 2022. PMID: 36462690. doi:10.1016/j.ijrobp.2022.11.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。